NICE Endorses Pegzilarginase for Treating Argin...

By HEOR Staff Writer

February 17, 2026

NICE Backs Pegzilarginase for Arginase Deficiency The National Institute for Health and Care Excellence (NICE) final draft guidance recommends pegzilarginase arginase deficiency trea...
Transformative PBM Reform Legislation Signed into Law
Advancing Cancer Screening in Slovenia: A Pathway to Equitable Care
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
Robotic Surgery Portugal: A Landmark Achievement at ULS Viseu Dão-Lafões
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
KEYTRUDA Ovarian Cancer Treatments: FDA Approves New Regimens for Platinum-Re...
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Advancements in Uncertainty-Aware Diagnostics with ConfiDx LLM
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes